| 2025-04-23 | +0.17 % |
|
| 2025-04-21 | -0.96 % |
|
| 2025-04-17 | +0.67 % |
|
| 2025-04-14 | +0.25 % |
|
| 2025-04-11 | +1.63 % |
|
| 2025-04-10 | -2.72 % |
|
| 2025-04-08 | -3.97 % |
|
| 2025-04-07 | +3.82 % |
|
| 2025-04-04 | -3.83 % |
|
| 2025-04-03 | -4.33 % |
|
| 2025-04-02 | +0.31 % |
|
| 2025-03-31 | +1.78 % |
|
| 2025-03-28 | -1.2 % |
|
| 2025-03-27 | +0.33 % |
|
| 2025-03-25 | -0.73 % |
|
| 2025-03-21 | -0.64 % |
|
| 2025-03-20 | -0.42 % |
|
| 2025-03-18 | -2 % |
|
| 2025-03-17 | +0.26 % |
|
| 2025-03-14 | +2.02 % |
|
| 2025-03-11 | -4.58 % |
|
| 2025-03-10 | +1.8 % |
|
| 2025-03-07 | +3.29 % |
|
| 2025-03-06 | +0.54 % |
|
| 2025-03-05 | -3.3 % |
|
| 2025-03-04 | -0.69 % |
|
| 2025-03-03 | -0.18 % |
|
| 2025-02-27 | -1.42 % |
|
| 2025-02-24 | -0.88 % |
|
| 2025-02-19 | +1.7 % |
|
| 2025-02-14 | -2.71 % |
|
| 2025-02-13 | +1.22 % |
|
| 2025-02-12 | -0.35 % |
|
| 2025-02-11 | -0.47 % |
|
| 2025-02-10 | +0.68 % |
|
| 2025-02-07 | -0.1 % |
|
| 2025-02-06 | -2.23 % |
|
| 2025-02-05 | +0.88 % |
|
| 2025-02-04 | -0.04 % |
|
| 2025-02-03 | +1.85 % |
|
| 2025-01-31 | -8.33 % |
|
| 2025-01-30 | +1.89 % |
- ResMed (RMD) stock rose by 1.89% due to positive market sentiments surrounding expected fiscal measures in the upcoming Union Budget 2025, which are anticipated to boost economic growth and consumer spending, reflecting wider optimism in the stock market.
- The article discusses the calm in global stock markets and highlights the mixed reactions to major tech earnings, noting that ResMed (RMD) stock rose by 1.89% amid broader market trends and speculation surrounding monetary policy and corporate results.
ResMed (RMD) stock likely increased due to positive market sentiment stemming from expected stable Federal Reserve policies and anticipation of favorable market conditions influenced by upcoming economic data releases.
- ResMed (RMD) stock rose by 1.89% to reach a four-year high of $40.75 amidst a day when the S&P/ASX 200 Index reached a new record, with several other shares also hitting multi-year peaks despite a lack of specific company news, indicating overall market optimism.
- ResMed Inc. (NYSE: RMD) saw a 1.89% increase in stock price due to impressive second quarter fiscal year 2025 results highlighted by a 10% revenue growth, margin expansion, and strong cash flow from increased demand for its sleep and breathing health products, as well as digital health solutions.
- ResMed (RMD) stock rose by 1.89% amid broader market optimism driven by the anticipation of positive developments from the upcoming Union Budget 2025, which is expected to focus on boosting consumption, infrastructure spending, and job creation.
|
| 2025-01-29 | +1.17 % |
|
| 2025-01-28 | -1.87 % |
|
| 2025-01-21 | +3.34 % |
|
| 2025-01-17 | +1.12 % |
|
| 2025-01-16 | +1.61 % |
|
| 2025-01-15 | +1.99 % |
|
| 2025-01-14 | -0.62 % |
|
| 2025-01-10 | -1 % |
|
| 2025-01-08 | -0.1 % |
|
| 2025-01-07 | +0.56 % |
|
| 2024-12-30 | -1.58 % |
|
| 2024-12-23 | -2.57 % |
|
| 2024-12-20 | +2.46 % |
|
| 2024-12-18 | -5.11 % |
|
| 2024-12-17 | +0.66 % |
|
| 2024-12-16 | +1.05 % |
|
| 2024-12-13 | -1.65 % |
|
| 2024-12-10 | +0.19 % |
|
| 2024-12-09 | +1.39 % |
|
| 2024-12-06 | +0.84 % |
|
| 2024-12-05 | -2.62 % |
|
| 2024-11-26 | +0.17 % |
|
| 2024-11-25 | +2.37 % |
|
| 2024-11-21 | +0.85 % |
|
| 2024-11-18 | +1.99 % |
|
| 2024-11-15 | +1.43 % |
|
| 2024-11-13 | -4.76 % |
|
| 2024-11-08 | +1.55 % |
|
| 2024-11-07 | +1.18 % |
|
| 2024-11-05 | +0.87 % |
|
| 2024-11-01 | +0.75 % |
|
| 2024-10-31 | -0.23 % |
|
| 2024-10-29 | -0.98 % |
|
| 2024-10-28 | -3.61 % |
|
